Metraipolis › archive › dc_e35890e00d03

IgG2a-formatted 4-1BB agonism combined with S100A9 inhibition enhances T cell activation and tumor control in a preclinical model of multiple myeloma — Europe PMC PMID:42082972

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42082972
DOI
10.1186/s13046-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-02T19:11:43.386Z
SHA-256 of the archived text
0cdf8c2ddd98753f39b29bacdb043cbab70c1ba212dc816e69a177e73a6863a8
Stable URL of this page
https://metraipolis.com/documento/dc_e35890e00d03

How to cite

IgG2a-formatted 4-1BB agonism combined with S100A9 inhibition enhances T cell activation and tumor control in a preclinical model of multiple myeloma — Europe PMC PMID:42082972 — Europe PMC (en), https://europepmc.org/article/MED/42082972 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e35890e00d03 (Metraipolis archive dc_e35890e00d03, sha256 0cdf8c2ddd98753f39b29bacdb043cbab70c1ba212dc816e69a177e73a6863a8)
BibTeX
@misc{dce35890e00d03,
  title = {IgG2a-formatted 4-1BB agonism combined with S100A9 inhibition enhances T cell activation and tumor control in a preclinical model of multiple myeloma — Europe PMC PMID:42082972},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42082972},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e35890e00d03; sha256 0cdf8c2ddd98753f39b29bacdb043cbab70c1ba212dc816e69a177e73a6863a8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42082972. Agents can read the archived copy with the MCP tool read_document.